Chattem, Inc.’s revenues for fiscal 2008 rose 7.4% to a record $454.9 million. According to the company, the gain was primarily driven by the five brands acquired from Johnson & Johnson in 2007, including Act, Cortizone-10 and Balmex. Net income for the fiscal year increased 11% to $66.3 million.
Fourth quarter revenues jumped 5% to $105.5 million. Revenue growth for the quarter was led by strong performances from Gold Bond, Icy Hot, Act, Aspercreme and Bullfrog, according to the company. Net income for the quarter rose 3% to $16.7 million.